Bolt Biotherapeutics (BOLT) Operating Expenses (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Operating Expenses of $7.6 million for Q1 2026, down 20.43% sequentially from $9.6 million in Q4 2025, and down 42.81% YoY from $13.3 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Operating Expenses (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Operating Expenses for 7 years, with the latest figure at $7.6 million in Q1 2026.
- Quarterly Operating Expenses fell 42.81% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.1 million (down 46.87% YoY) and the FY2025 annual result came in at $43.8 million, down 45.74% from the prior year.
- Operating Expenses eased to $7.6 million in Q1 2026 per BOLT's latest filing, from $9.6 million in the prior quarter.
- Over five years, Operating Expenses peaked at $24.7 million in Q1 2022 and troughed at $7.6 million in Q1 2026.
- A 5-year average of $18.4 million and a median of $20.7 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 33.99% in 2022, then sank 53.86% in 2025.
- Over 5 years, Operating Expenses stood at $22.5 million in 2022, then dropped by 2.65% to $21.9 million in 2023, then slipped by 22.6% to $16.9 million in 2024, then slumped by 43.34% to $9.6 million in 2025, then dropped by 20.43% to $7.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $7.6 million, $9.6 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.38 Mn |
| Mar 31, 2026 | 7.63 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 9.87 Mn |
| Jun 30, 2025 | 11.01 Mn |
| Mar 31, 2025 | 13.34 Mn |
| Dec 31, 2024 | 16.92 Mn |
| Sep 30, 2024 | 17.58 Mn |
| Jun 30, 2024 | 23.87 Mn |
| Mar 31, 2024 | 22.37 Mn |
| Dec 31, 2023 | 21.86 Mn |
| Sep 30, 2023 | 20.71 Mn |
| Jun 30, 2023 | 21.27 Mn |
| Mar 31, 2023 | 20.24 Mn |
| Dec 31, 2022 | 22.45 Mn |
| Sep 30, 2022 | 24.46 Mn |
| Jun 30, 2022 | 24.45 Mn |
| Mar 31, 2022 | 24.69 Mn |
| Dec 31, 2021 | 27.58 Mn |
| Sep 30, 2021 | 24.28 Mn |